Skip to content
10-Q

Quarterly Report

Cartesian Therapeutics, Inc. RNAC

0001453687-25-000099

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 26M sh
Shares Diluted Q2 2025 · Jun 30, 2025 26.45M sh
Shares Diluted Q2 2025 · Jun 30, 2025 25.94M sh
Shares Diluted Q2 2025 · Jun 30, 2024 17.79M sh
Shares Diluted Q2 2025 · Jun 30, 2024 11.07M sh
Capex Q2 2025 · Jun 30, 2025 $3.67M
Capex Q2 2025 · Jun 30, 2024 $2.19M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$40.63M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$30.36M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $160.32M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $212.61M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $87.23M
Stockholders Equity Q2 2025 · Jun 30, 2025 −$2.53M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$21.79M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$6.8M
Stockholders Equity Q2 2025 · Jun 30, 2024 −$101.46M
Stockholders Equity Q2 2025 · Mar 31, 2024 −$116.8M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$440.18M
Current Liabilities Q2 2025 · Jun 30, 2025 $12.26M
Current Liabilities Q2 2025 · Dec 31, 2024 $22.98M
Total Liabilities Q2 2025 · Jun 30, 2025 $391.42M
Total Liabilities Q2 2025 · Dec 31, 2024 $441.83M
Current Assets Q2 2025 · Jun 30, 2025 $163.4M
Current Assets Q2 2025 · Dec 31, 2024 $216.63M
Total Assets Q2 2025 · Jun 30, 2025 $388.89M
Total Assets Q2 2025 · Dec 31, 2024 $435.02M
Eps Diluted Q2 2025 · Jun 30, 2025 $0.50
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.07
Eps Diluted Q2 2025 · Jun 30, 2024 $0.54
Eps Diluted Q2 2025 · Jun 30, 2024 −$3.88
Eps Basic Q2 2025 · Jun 30, 2025 $0.51
Eps Basic Q2 2025 · Jun 30, 2025 −$0.07
Eps Basic Q2 2025 · Jun 30, 2024 $0.58
Eps Basic Q2 2025 · Jun 30, 2024 −$3.88
Sga Expense Q2 2025 · Jun 30, 2025 $7.24M
Sga Expense Q2 2025 · Jun 30, 2025 $15.56M
Sga Expense Q2 2025 · Jun 30, 2024 $7.03M
Sga Expense Q2 2025 · Jun 30, 2024 $16.48M
Rd Expense Q2 2025 · Jun 30, 2025 $14.87M
Rd Expense Q2 2025 · Jun 30, 2025 $29.54M
Rd Expense Q2 2025 · Jun 30, 2024 $12.66M
Rd Expense Q2 2025 · Jun 30, 2024 $22.4M
Net Income Q2 2025 · Jun 30, 2025 $15.89M
Net Income Q2 2025 · Jun 30, 2025 −$1.82M
Net Income Q2 2025 · Mar 31, 2025 −$17.71M
Net Income Q2 2025 · Jun 30, 2024 $13.84M
Net Income Q2 2025 · Jun 30, 2024 −$42.99M
Net Income Q2 2025 · Mar 31, 2024 −$56.82M
Operating Income Q2 2025 · Jun 30, 2025 −$21.81M
Operating Income Q2 2025 · Jun 30, 2025 −$43.7M
Operating Income Q2 2025 · Jun 30, 2024 $13.76M
Operating Income Q2 2025 · Jun 30, 2024 $409K
Revenue Q2 2025 · Jun 30, 2025 $0
Revenue Q2 2025 · Jun 30, 2025 $400K
Revenue Q2 2025 · Jun 30, 2024 $33.27M
Revenue Q2 2025 · Jun 30, 2024 $39.11M